Top Markets
#1 CoW Protocol CoW Protocol +59.73%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +39.17%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.40%
#6 Humanity Humanity +22.30%
#7 Enso Enso +17.07%
#8 Velvet Velvet +17.00%
#9 Tutorial Tutorial +16.94%
#10 Huma Finance Huma Finance +14.02%
Coin of the day
CoW Protocol CoW Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
China Dasheng Biotechnology Company China Dasheng Biotechnology Company

China Dasheng Biotechnology Company

CDBT
Classifica tra le azioni #37246
China Dasheng Biotechnology Company, alongside its various divisions, is... China Dasheng Biotechnology Company, alongside its various divisions, is dedicated to the creation, promotion, and distribution of microbial products within the People's Republic of China. These specialized solutions primarily function as beneficial additives for both livestock feed and agricultural cultivation. The company's product line features proprietary blends of Artificial Microorganisms (AM) and High-efficiency Microorganisms (HM), in addition to biological preservatives. Its AM/HM bacteria-based additives for crops, including specific strains like Bulgaria lactobacillus, beer microzyme, and dark red spirilla, are formulated to significantly boost beneficial microbial populations in soil. They also work to counteract the proliferation of harmful fungi and putrefactive bacteria, thereby optimizing nutrient absorption and helping to reduce the incidence of diseases in both plants and animals. For animal nutrition, the AM/HM bacteria-based feed additives are designed to improve the texture of livestock feed and inhibit the growth of pathogenic bacteria. Moreover, they deliver essential nutrients such as organic acids, vitamins, enzymes, natural antibiotics, mycelial protein, and various other growth-promoting substances to ensure a balanced nutritional profile in the feed. The FGW bacterial preservatives serve a dual purpose: preserving animal specimens for scientific research and extending the shelf life of agricultural produce. Furthermore, the company supplies bacteria-based fertilizers intended for application directly onto plant foliage, particularly for vegetables and fruits. Beyond its biotechnology endeavors, China Dasheng Biotechnology Company also holds investments in the residential and commercial real estate sectors. The enterprise was previously known as Max Nutrition, Inc., before officially adopting its current name, China Dasheng Biotechnology Company, in March 2008. Its operational headquarters are situated in Lanzhou, China.
Prezzo delle azioni
$0.046
Ultima sincronizzazione: 2025-07-10
Capitalizzazione di mercato
$1.88M
Variazione (1 giorno)
-54.00%
Variazione (1 anno)
0.00%
Paese
CN
Scambia China Dasheng Biotechnology Company (CDBT)

Categoria

Financial Services
Rapporto P/E per China Dasheng Biotechnology Company (CDBT)
Rapporto P/E al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di China Dasheng Biotechnology Company, il rapporto P/E attuale (TTM) è 0. Alla fine del 2026, il rapporto P/E era 0.
Storico del rapporto P/E per China Dasheng Biotechnology Company da 2026 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
Non abbastanza dati per le date fornite.
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
Clone Algo Technologies Inc. Clone Algo Technologies Inc.
Clone Algo Technologies Inc.
CATI.US
 - -
US
Worldwide Webb Acquisition Corp. Worldwide Webb Acquisition Corp.
Worldwide Webb Acquisition Corp.
WWAC.US
 - -
US
Gushen, Inc. Gushen, Inc.
Gushen, Inc.
GSHN.US
 - -
CN
Apollo Strategic Growth Capital Apollo Strategic Growth Capital
Apollo Strategic Growth Capital
APSG.US
 - -
US
Digital World Acquisition Corp. Digital World Acquisition Corp.
Digital World Acquisition Corp.
DWAC.US
 - -
US
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.